The Tough Tech problem we are solving
SUTOL Bio is addressing the challenge of long-term treatment for chronic conditions where daily pills are hard to maintain and existing long-acting injectables can be painful, clinic-dependent, and irreversible once administered. Many patients struggle with adherence over months and years, which undermines otherwise effective therapies and leaves a gap for a safe, convenient, and retrievable long-acting option that fits into routine pharmacy care.
About our solution
SUTOL Bio is developing the Monthly Oral Capsule Platform, a first-in-class oral delivery system designed to provide continuous drug release for more than 30 days from a single monthly dose, eliminating the burden of daily pills and injections. Originating from six years of translational research in the Langer and Traverso laboratories at MIT, the platform combines advanced drug delivery science and biomedical engineering to offer a patient-friendly, cost-effective oral therapy that maintains consistent exposure while being dispensed through standard pharmacy channels.